Neuberger Berman Group LLC Pacira Bio Sciences, Inc. Transaction History

Neuberger Berman Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $951,998 - $1.51 Million	-18,489 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$60.03 - $76.49 $581,090 - $740,423	9,680 Added 109.89%	18,489 $1.4 Million
Q4 2021 Feb 11, 2022	SELL	$47.97 - $62.21 $1.29 Million - $1.67 Million	-26,840 Reduced 75.29%	8,809 $525,000
Q3 2021 Nov 12, 2021	SELL	$54.64 - $61.3 $847,466 - $950,763	-15,510 Reduced 30.32%	35,649 $2 Million
Q2 2021 Aug 13, 2021	SELL	$59.18 - $69.99 $419,408 - $496,019	-7,087 Reduced 12.17%	51,159 $3.1 Million
Q1 2021 May 13, 2021	BUY	$59.31 - $78.82 $2.22 Million - $2.95 Million	37,484 Added 180.54%	58,246 $4.08 Million
Q4 2020 Feb 10, 2021	BUY	$50.47 - $66.26 $182,348 - $239,397	3,613 Added 21.07%	20,762 $1.24 Million
Q3 2020 Nov 12, 2020	BUY	$51.97 - $63.0 $891,233 - $1.08 Million	17,149 New	17,149 $1.03 Million

301

51.5M

378K

1.53M

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $666M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.